{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:48:45Z","timestamp":1793148525685,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T00:00:00Z","timestamp":1211328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T00:00:00Z","timestamp":1211328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s11095-008-9571-x","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T11:16:59Z","timestamp":1211282219000},"page":"1751-1761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases"],"prefix":"10.1007","volume":"25","author":[{"given":"Carlos G.","family":"Leon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Tory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor M.","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,21]]},"reference":[{"key":"9571_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/714028139","volume":"76","author":"T. J. Beveridge","year":"2001","unstructured":"T. J. Beveridge. Use of the gram stain in microbiology. Biotech. Histochem.\n                           76:111\u2013118 (2001).","journal-title":"Biotech. Histochem."},{"key":"9571_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"C. A. Janeway Jr","year":"2002","unstructured":"C. A. Janeway Jr, and R. Medzhitov. Innate immune recognition. Annu. Rev. Immunol.\n                           20:197\u2013216 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"9571_CR3","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1074\/jbc.274.16.10689","volume":"274","author":"J. C. Chow","year":"1999","unstructured":"J. C. Chow, D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem.\n                           274:10689\u201310692 (1999).","journal-title":"J. Biol. Chem."},{"key":"9571_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/1568005014606143","volume":"1","author":"J. A. Yethon","year":"2001","unstructured":"J. A. Yethon, and C. Whitfield. Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria. Curr. Drug Targets Infect. Disord.\n                           1:91\u2013106 (2001).","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"9571_CR5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-113-3-227","volume":"113","author":"J. E. Parrillo","year":"1990","unstructured":"J. E. Parrillo, M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Cunnion, and F. P. Ognibene. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med.\n                           113:227\u2013242 (1990).","journal-title":"Ann. Intern. Med."},{"key":"9571_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.biochem.76.060305.151318","volume":"76","author":"N. J. Gay","year":"2007","unstructured":"N. J. Gay, and M. Gangloff. Structure and function of toll receptors and their ligands. Annu. Rev. Biochem.\n                           76:141\u2013165 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"9571_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0024-3205(00)00939-5","volume":"68","author":"T. K. Means","year":"2000","unstructured":"T. K. Means, D. T. Golenbock, and M. J. Fenton. Structure and function of Toll-like receptor proteins. Life Sci.\n                           68:241\u2013258 (2000).","journal-title":"Life Sci."},{"key":"9571_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0092-8674(88)90516-8","volume":"52","author":"C. Hashimoto","year":"1988","unstructured":"C. Hashimoto, K. L. Hudson, and K. V. Anderson. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell. 52:269\u2013279 (1988).","journal-title":"Cell"},{"key":"9571_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bcp.2006.07.010","volume":"72","author":"S. L. Doyle","year":"2006","unstructured":"S. L. Doyle, and L. A. O\u2019Neill. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol.\n                           72:1102\u20131113 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"9571_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nri2079","volume":"7","author":"L. A. O\u2019Neill","year":"2007","unstructured":"L. A. O\u2019Neill, and A. G. Bowie. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol.\n                           7:353\u2013364 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"9571_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nri1630","volume":"5","author":"F. Y. Liew","year":"2005","unstructured":"F. Y. Liew, D. Xu, E. K. Brint, and L. A. O\u2019Neill. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol.\n                           5:446\u2013458 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"9571_CR12","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.2174\/138161206778743501","volume":"12","author":"L. L. Stoll","year":"2006","unstructured":"L. L. Stoll, G. M. Denning, and N. L. Weintraub. Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. Curr. Pharm. Des.\n                           12:4229\u20134245 (2006).","journal-title":"Curr. Pharm. Des."},{"key":"9571_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R. Medzhitov","year":"1997","unstructured":"R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:394\u2013397 (1997).","journal-title":"Nature"},{"key":"9571_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ni926","volume":"4","author":"B. A. Jude","year":"2003","unstructured":"B. A. Jude, Y. Pobezinskaya, J. Bishop, S. Parke, R. M. Medzhitov, A. V. Chervonsky, and T. V. Golovkina. Subversion of the innate immune system by a retrovirus. Nat. Immunol.\n                           4:573\u2013578 (2003).","journal-title":"Nat. Immunol."},{"key":"9571_CR15","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1074\/jbc.M100099200","volume":"276","author":"Y. Okamura","year":"2001","unstructured":"Y. Okamura, M. Watari, E. S. Jerud, D. W. Young, S. T. Ishizaka, J. Rose, J. C. Chow, and J. F. Strauss 3rd. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem.\n                           276:10229\u201310233 (2001).","journal-title":"J. Biol. Chem."},{"key":"9571_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.1206730","volume":"82","author":"S. P. Gondokaryono","year":"2007","unstructured":"S. P. Gondokaryono, H. Ushio, F. Niyonsaba, M. Hara, H. Takenaka, S. T. Jayawardana, S. Ikeda, K. Okumura, and H. Ogawa. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J. Leukoc. Biol.\n                           82:657\u2013665 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"9571_CR17","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1126\/science.1698311","volume":"249","author":"S. D. Wright","year":"1990","unstructured":"S. D. Wright, R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1431\u20131433 (1990).","journal-title":"Science"},{"key":"9571_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/eji.200535777","volume":"36","author":"J. C. Sirard","year":"2006","unstructured":"J. C. Sirard, M. Bayardo, and A. Didierlaurent. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors. Eur. J. Immunol.\n                           36:260\u2013263 (2006).","journal-title":"Eur. J. Immunol."},{"key":"9571_CR19","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","volume":"189","author":"R. Shimazu","year":"1999","unstructured":"R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med.\n                           189:1777\u20131782 (1999).","journal-title":"J. Exp. Med."},{"key":"9571_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijmm.2007.04.001","volume":"297","author":"R. Jerala","year":"2007","unstructured":"R. Jerala. Structural biology of the LPS recognition. Int. J. Med. Microbiol.\n                           297:353\u2013363 (2007).","journal-title":"Int. J. Med. Microbiol."},{"key":"9571_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ni1207","volume":"6","author":"Z. Jiang","year":"2005","unstructured":"Z. Jiang, P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, C. Galanos, M. Freudenberg, and B. Beutler. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol.\n                           6:565\u2013570 (2005).","journal-title":"Nat. Immunol."},{"key":"9571_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2174\/1568026043388123","volume":"4","author":"L. D. Hawkins","year":"2004","unstructured":"L. D. Hawkins, W. J. Christ, and D. P. Rossignol. Inhibition of endotoxin response by synthetic TLR4 antagonists. Curr. Top Med. Chem.\n                           4:1147\u20131171 (2004).","journal-title":"Curr. Top Med. Chem."},{"key":"9571_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/thx.2006.061358","volume":"62","author":"J. L. Simpson","year":"2007","unstructured":"J. L. Simpson, T. V. Grissell, J. Douwes, R. J. Scott, M. J. Boyle, and P. G. Gibson. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 62:211\u2013218 (2007).","journal-title":"Thorax"},{"key":"9571_CR24","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1161\/res.95.12.e96","volume":"95","author":"K. S. Michelsen","year":"2004","unstructured":"K. S. Michelsen, T. M. Doherty, P. K. Shah, and M. Arditi. Role of Toll-like receptors in atherosclerosis. Circ. Res.\n                           95:e96\u2013e97 (2004).","journal-title":"Circ. Res."},{"key":"9571_CR25","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.172.4.2629","volume":"172","author":"P. N. Cunningham","year":"2004","unstructured":"P. N. Cunningham, Y. Wang, R. Guo, G. He, and R. J. Quigg. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J. Immunol.\n                           172:2629\u20132635 (2004).","journal-title":"J. Immunol."},{"key":"9571_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jhep.2006.06.017","volume":"45","author":"A. Velayudham","year":"2006","unstructured":"A. Velayudham, I. Hritz, A. Dolganiuc, P. Mandrekar, E. Kurt-Jones, and G. Szabo. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J. Hepatol.\n                           45:813\u2013824 (2006).","journal-title":"J. Hepatol."},{"key":"9571_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1034\/j.1600-0528.2002.017411.x","volume":"174","author":"A. M. Diehl","year":"2000","unstructured":"A. M. Diehl. Cytokine regulation of liver injury and repair. Immunol. Rev.\n                           174:160\u2013171 (2000).","journal-title":"Immunol. Rev."},{"key":"9571_CR28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jlb.67.6.767","volume":"67","author":"J. M. Schuster","year":"2000","unstructured":"J. M. Schuster, and P. S. Nelson. Toll receptors: an expanding role in our understanding of human disease. J. Leukoc. Biol.\n                           67:767\u2013773 (2000).","journal-title":"J. Leukoc. Biol."},{"key":"9571_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cellbi.2007.01.034","volume":"31","author":"H. Li","year":"2007","unstructured":"H. Li, Y. He, J. Zhang, S. Sun, and B. Sun. Lipopolysaccharide regulates toll-like receptor 4 expression in human aortic smooth muscle cells. Cell Biol. Int.\n                           31:831\u2013835 (2007).","journal-title":"Cell Biol. Int."},{"key":"9571_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1397.064","volume":"1096","author":"H. Bosshart","year":"2007","unstructured":"H. Bosshart, and M. Heinzelmann. Targeting bacterial endotoxin: two sides of a coin. Ann. N. Y. Acad. Sci.\n                           1096:1\u201317 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"9571_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00134-006-0433-x","volume":"33","author":"M. Wendel","year":"2007","unstructured":"M. Wendel, R. Paul, and A. R. Heller. Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive. Care Med.\n                           33:25\u201335 (2007).","journal-title":"Intensive. Care Med."},{"key":"9571_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","volume":"13","author":"M. Guha","year":"2001","unstructured":"M. Guha, and N. Mackman. LPS induction of gene expression in human monocytes. Cell Signal. 13:85\u201394 (2001).","journal-title":"Cell Signal"},{"key":"9571_CR33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","volume":"105","author":"K. Edfeldt","year":"2002","unstructured":"K. Edfeldt, J. Swedenborg, G. K. Hansson, and Z. Q. Yan. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 105:1158\u20131161 (2002).","journal-title":"Circulation"},{"key":"9571_CR34","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","volume":"167","author":"S. T. Smiley","year":"2001","unstructured":"S. T. Smiley, J. A. King, and W. W. Hancock. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol.\n                           167:2887\u20132894 (2001).","journal-title":"J. Immunol."},{"key":"9571_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1071-5576(00)00054-X","volume":"7","author":"M. Watari","year":"2000","unstructured":"M. Watari, H. Watari, I. Nachamkin, and J. F. Strauss. Lipopolysaccharide induces expression of genes encoding pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin S, in human cervical smooth-muscle cells. J. Soc. Gynecol. Investig.\n                           7:190\u2013198 (2000).","journal-title":"J. Soc. Gynecol. Investig."},{"key":"9571_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/hh1501.094184","volume":"89","author":"S. Sasu","year":"2001","unstructured":"S. Sasu, D. LaVerda, N. Qureshi, D. T. Golenbock, and D. Beasley. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44\/p42 mitogen-activated protein kinase activation. Circ. Res.\n                           89:244\u2013250 (2001).","journal-title":"Circ. Res."},{"key":"9571_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1399-302X.2006.00278.x","volume":"21","author":"D. Grenier","year":"2006","unstructured":"D. Grenier, and L. Grignon. Response of human macrophage-like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharide. Oral Microbiol Immunol.\n                           21:190\u2013196 (2006).","journal-title":"Oral Microbiol Immunol."},{"key":"9571_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00011-006-0082-0","volume":"55","author":"S. M. Riordan","year":"2006","unstructured":"S. M. Riordan, N. A. Skinner, J. Kurtovic, S. Locarnini, C. J. McIver, R. Williams, and K. Visvanathan. Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury. Inflamm. Res.\n                           55:279\u2013285 (2006).","journal-title":"Inflamm. Res."},{"key":"9571_CR39","doi-asserted-by":"crossref","first-page":"G256","DOI":"10.1152\/ajpgi.00550.2001","volume":"283","author":"G. L. Su","year":"2002","unstructured":"G. L. Su. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. Gastrointest. Liver Physiol.\n                           283:G256\u2013G265 (2002).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"9571_CR40","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.4049\/jimmunol.175.11.7661","volume":"175","author":"A. Tsung","year":"2005","unstructured":"A. Tsung, R. A. Hoffman, K. Izuishi, N. D. Critchlow, A. Nakao, M. H. Chan, M. T. Lotze, D. A. Geller, and T. R. Billiar. Hepatic ischemia\/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J. Immunol.\n                           175:7661\u20137668 (2005).","journal-title":"J. Immunol."},{"key":"9571_CR41","doi-asserted-by":"publisher","first-page":"I270","DOI":"10.1161\/CIRCULATIONAHA.105.000901","volume":"114","author":"A. Shimamoto","year":"2006","unstructured":"A. Shimamoto, A. J. Chong, M. Yada, S. Shomura, H. Takayama, A. J. Fleisig, M. L. Agnew, C. R. Hampton, C. L. Rothnie, D. J. Spring, T. H. Pohlman, H. Shimpo, and E. D. Verrier. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation. 114:I270\u20134 (2006).","journal-title":"Circulation"},{"key":"9571_CR42","doi-asserted-by":"publisher","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","volume":"290","author":"J. S. Park","year":"2006","unstructured":"J. S. Park, F. Gamboni-Robertson, Q. He, D. Svetkauskaite, J. Y. Kim, D. Strassheim, J. W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, A. Ishizaka, and E. Abraham. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell. Physiol.\n                           290:C917\u2013C924 (2006).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"9571_CR43","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/01.tp.0000287597.87571.17","volume":"84","author":"D. J. Kaczorowski","year":"2007","unstructured":"D. J. Kaczorowski, A. Nakao, K. P. Mollen, R. Vallabhaneni, R. Sugimoto, J. Kohmoto, K. Tobita, B. S. Zuckerbraun, K. R. McCurry, N. Murase, and T. R. Billiar. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia\/reperfusion. Transplantation. 84:1279\u20131287 (2007).","journal-title":"Transplantation"},{"key":"9571_CR44","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.4049\/jimmunol.178.11.7317","volume":"178","author":"F. Hua","year":"2007","unstructured":"F. Hua, T. Ha, J. Ma, Y. Li, J. Kelley, X. Gao, I. W. Browder, R. L. Kao, D. L. Williams, and C. Li. Protection against myocardial ischemia\/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immunol.\n                           178:7317\u20137324 (2007).","journal-title":"J. Immunol."},{"key":"9571_CR45","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/01.ASN.0000121781.89599.16","volume":"15","author":"H. J. Anders","year":"2004","unstructured":"H. J. Anders, B. Banas, and D. Schlondorff. Signaling danger: toll-like receptors and their potential roles in kidney disease. J. Am. Soc. Nephrol.\n                           15:854\u2013867 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9571_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/MNH.0b013e3280403c4e","volume":"16","author":"C. Y. Lu","year":"2007","unstructured":"C. Y. Lu, J. Hartono, M. Senitko, and J. Chen. The inflammatory response to ischemic acute kidney injury: a result of the \u2018right stuff\u2019 in the \u2018wrong place\u2019? Curr. Opin. Nephrol. Hypertens.\n                           16:83\u201389 (2007).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"9571_CR47","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.intimp.2007.04.003","volume":"7","author":"M. Yu","year":"2007","unstructured":"M. Yu, D. Shao, J. Liu, J. Zhu, Z. Zhang, and J. Xu. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis. Int. Immunopharmacol.\n                           7:1076\u20131082 (2007).","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl 2","key":"9571_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2036.2007.03476.x","volume":"26","author":"R. K. Weersma","year":"2007","unstructured":"R. K. Weersma, H. M. van Dullemen, G. van der Steege, I. M. Nolte, J. H. Kleibeuker, and G. Dijkstra. Review article: Inflammatory bowel disease and genetics. Aliment. Pharmacol. Ther.\n                           26(Suppl 2):57\u201365 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"9571_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.gene.6364398","volume":"8","author":"P. L. De Jager","year":"2007","unstructured":"P. L. De Jager, D. Franchimont, A. Waliszewska, A. Bitton, A. Cohen, D. Langelier, J. Belaiche, S. Vermeire, L. Farwell, A. Goris, C. Libioulle, N. Jani, T. Dassopoulos, G. P. Bromfield, B. Dubois, J. H. Cho, S. R. Brant, R. H. Duerr, H. Yang, J. I. Rotter, M. S. Silverberg, A. H. Steinhart, M. J. Daly, D. K. Podolsky, E. Louis, D. A. Hafler, and J. D. Rioux. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun.\n                           8:387\u2013397 (2007).","journal-title":"Genes Immun."},{"key":"9571_CR50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00535-004-1492-9","volume":"40","author":"A. Araki","year":"2005","unstructured":"A. Araki, T. Kanai, T. Ishikura, S. Makita, K. Uraushihara, R. Iiyama, T. Totsuka, K. Takeda, S. Akira, and M. Watanabe. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol.\n                           40:16\u201323 (2005).","journal-title":"J. Gastroenterol."},{"key":"9571_CR51","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.4049\/jimmunol.174.10.6416","volume":"174","author":"M. M. Fort","year":"2005","unstructured":"M. M. Fort, A. Mozaffarian, A. G. Stover, S. Correia Jda, D. A. Johnson, R. T. Crane, R. J. Ulevitch, D. H. Persing, H. Bielefeldt-Ohmann, P. Probst, E. Jeffery, S. P. Fling, and R. M. Hershberg. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J. Immunol.\n                           174:6416\u20136423 (2005).","journal-title":"J. Immunol."},{"key":"9571_CR52","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1017\/S0265021506001098","volume":"23","author":"G. Baumgarten","year":"2006","unstructured":"G. Baumgarten, P. Knuefermann, H. Wrigge, C. Putensen, H. Stapel, K. Fink, R. Meyer, A. Hoeft, and C. Grohe. Role of Toll-like receptor 4 for the pathogenesis of acute lung injury in Gram-negative sepsis. Eur. J. Anaesthesiol.\n                           23:1041\u20131048 (2006).","journal-title":"Eur. J. Anaesthesiol."},{"key":"9571_CR53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1365-3083.2003.01339.x","volume":"58","author":"J. Qu","year":"2003","unstructured":"J. Qu, J. Zhang, J. Pan, L. He, Z. Ou, X. Zhang, and X. Chen. Endotoxin tlerance inhibits lipopolysaccharide-initiated acute pulmonary inflammation and lung injury in rats by the mechanism of nuclear factor-kappaB. Scand. J. Immunol.\n                           58:613\u2013619 (2003).","journal-title":"Scand. J. Immunol."},{"key":"9571_CR54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/156802608783378882","volume":"8","author":"D. A. Johnson","year":"2008","unstructured":"D. A. Johnson. Synthetic TLR4-active Glycolipids as Vaccine Adjuvants and Stand-alone Immunotherapeutics. Curr. Top. Med. Chem.\n                           8:64\u201379 (2008).","journal-title":"Curr. Top. Med. Chem."},{"key":"9571_CR55","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0960-894X(99)00374-1","volume":"9","author":"D. A. Johnson","year":"1999","unstructured":"D. A. Johnson, C. G. Sowell, C. L. Johnson, M. T. Livesay, D. S. Keegan, M. J. Rhodes, J. T. Ulrich, J. R. Ward, J. L. Cantrell, and V. G. Brookshire. Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs). Bioorg. Med. Chem. Lett.\n                           9:2273\u20132278 (1999).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"9571_CR56","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.7701344","volume":"268","author":"W. J. Christ","year":"1995","unstructured":"W. J. Christ, O. Asano, A. L. Robidoux, M. Perez, Y. Wang, G. R. Dubuc, W. E. Gavin, L. D. Hawkins, P. D. McGuinness, and M. A. Mullarkey. E5531, a pure endotoxin antagonist of high potency. Science. 268:80\u201383 (1995).","journal-title":"Science"},{"key":"9571_CR57","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","volume":"130","author":"H. M. Kim","year":"2007","unstructured":"H. M. Kim, B. S. Park, J. I. Kim, S. E. Kim, J. Lee, S. C. Oh, P. Enkhbayar, N. Matsushima, H. Lee, O. J. Yoo, and J. O. Lee. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 130:906\u2013917 (2007).","journal-title":"Cell"},{"key":"9571_CR58","first-page":"499","volume":"392","author":"T. Kawata","year":"1995","unstructured":"T. Kawata, J. R. Bristol, J. R. Rose, D. P. Rossignol, W. J. Christ, O. Asano, G. R. Dubuc, W. E. Gavin, L. D. Hawkins, and Y. Kishi. Anti-endotoxin activity of a novel synthetic lipid A analog. Prog. Clin. Biol. Res.\n                           392:499\u2013509 (1995).","journal-title":"Prog. Clin. Biol. Res."},{"key":"9571_CR59","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.43.10.2562","volume":"43","author":"K. M. Wasan","year":"1999","unstructured":"K. M. Wasan, F. W. Strobel, S. C. Parrott, M. Lynn, W. J. Christ, L. D. Hawkins, and D. P. Rossignol. Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levels. Antimicrob. Agents Chemother.\n                           43:2562\u20132564 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9571_CR60","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/AAC.44.3.504-510.2000","volume":"44","author":"J. R. Rose","year":"2000","unstructured":"J. R. Rose, M. A. Mullarkey, W. J. Christ, L. D. Hawkins, M. Lynn, Y. Kishi, K. M. Wasan, K. Peteherych, and D. P. Rossignol. Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins. Antimicrob. Agents Chemother.\n                           44:504\u2013510 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9571_CR61","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1124\/jpet.102.044487","volume":"304","author":"M. Mullarkey","year":"2003","unstructured":"M. Mullarkey, J. R. Rose, J. Bristol, T. Kawata, A. Kimura, S. Kobayashi, M. Przetak, J. Chow, F. Gusovsky, W. J. Christ, and D. P. Rossignol. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J. Pharmacol. Exp. Ther.\n                           304:1093\u20131102 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9571_CR62","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1074\/jbc.M009040200","volume":"276","author":"E. Lien","year":"2001","unstructured":"E. Lien, J. C. Chow, L. D. Hawkins, P. D. McGuinness, K. Miyake, T. Espevik, F. Gusovsky, and D. T. Golenbock. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide\/toll-like receptor 4 signaling pathway. J. Biol. Chem.\n                           276:1873\u20131880 (2001).","journal-title":"J. Biol. Chem."},{"key":"9571_CR63","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1161\/01.ATV.0000168410.44722.86","volume":"25","author":"H. Methe","year":"2005","unstructured":"H. Methe et al. Statins decrease toll-like receptor 4 expression and downstream signaling in human CD14 monocytes. Arterioscler. Thromb. Vasc. Biol.\n                           25:1439 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"9571_CR64","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1128\/AAC.47.9.2796-2803.2003","volume":"47","author":"K. M. Wasan","year":"2003","unstructured":"K. M. Wasan, O. Sivak, R. A. Cote, A. I. MacInnes, K. D. Boulanger, M. Lynn, W. J. Christ, L. D. Hawkins, and D. P. Rossignol. Association of the endotoxin antagonist E5564 with high-density lipoproteins in vitro: dependence on low-density and triglyceride-rich lipoprotein concentrations. Antimicrob. Agents Chemother.\n                           47:2796\u20132803 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9571_CR65","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1086\/315093","volume":"180","author":"S. M. Opal","year":"1999","unstructured":"S. M. Opal, P. J. Scannon, J. L. Vincent, M. White, S. F. Carroll, J. E. Palardy, N. A. Parejo, J. P. Pribble, and J. H. Lemke. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis.\n                           180:1584\u20131589 (1999).","journal-title":"J. Infect. Dis."},{"key":"9571_CR66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/367990","volume":"187","author":"M. Lynn","year":"2003","unstructured":"M. Lynn, D. P. Rossignol, J. L. Wheeler, R. J. Kao, C. A. Pardomo, R. Noveck, R. Vargas, T. D\u2019Angelo, S. Gotzkowsky, and F. G. McMahon. Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia. J. Infect. Dis.\n                           187:631\u2013639 (2003).","journal-title":"J. Infect. Dis."},{"key":"9571_CR67","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1128\/AAC.48.9.3233-3240.2004","volume":"48","author":"D. P. Rossignol","year":"2004","unstructured":"D. P. Rossignol, K. M. Wasan, E. Choo, E. Yau, N. Wong, J. Rose, J. Moran, and M. Lynn. Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran (E5564) during continuous intravenous infusion into healthy volunteers. Antimicrob. Agents Chemother.\n                           48:3233\u20133240 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9571_CR68","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/mol.105.019695","volume":"69","author":"M. Ii","year":"2006","unstructured":"M. Ii et al. A novel cyclohexene derivative, ethyl (6 R)-6-[N-(2-chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol.\n                           69:1288 (2006).","journal-title":"Mol. Pharmacol."},{"key":"9571_CR69","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejphar.2007.06.027","volume":"571","author":"T. Sha","year":"2007","unstructured":"T. Sha, M. Sunamoto, T. Kitazaki, J. Sato, M. Ii, and Y. Iizawa. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur. J. Pharmacol.\n                           571:231\u2013239 (2007).","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"9571_CR70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","volume":"581","author":"T. Kawamoto","year":"2008","unstructured":"T. Kawamoto, M. Ii, T. Kitazaki, Y. Iizawa, and H. Kimura. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur. J. Pharmacol.\n                           584(1):40\u20138 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"9571_CR71","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1097\/00003246-200107001-00035","volume":"29","author":"D. C. Angus","year":"2001","unstructured":"D. C. Angus, and R. S. Wax. Epidemiology of sepsis: an update. Crit. Care Med.\n                           29:S109\u2013S116 (2001).","journal-title":"Crit. Care Med."},{"key":"9571_CR72","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"R. S. Hotchkiss","year":"2003","unstructured":"R. S. Hotchkiss, and I. E. Karl. The Pathophysiology and Treatment of Sepsis. N. Engl. J. Med.\n                           348:138 (2003).","journal-title":"N. Engl. J. Med."},{"key":"9571_CR73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00003246-200301001-00012","volume":"31","author":"G. Bernard","year":"2003","unstructured":"G. Bernard. Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit. Care Med.\n                           31:85\u201393 (2003).","journal-title":"Crit. Care Med."},{"key":"9571_CR74","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0091270003254804","volume":"43","author":"Y. N. Wong","year":"2003","unstructured":"Y. N. Wong, D. Rossignol, J. R. Rose, R. Kao, A. Carter, and M. Lynn. Safety, pharmacokinetics, and pharmacodynamics of E5564, a lipid A antagonist, during an ascending single-dose clinical study. J. Clin. Pharmacol.\n                           43:735\u2013742 (2003).","journal-title":"J. Clin. Pharmacol."},{"key":"9571_CR75","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1213\/01.ane.0000253501.07183.2a","volume":"104","author":"E. Bennett-Guerrero","year":"2007","unstructured":"E. Bennett-Guerrero. A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth. Analg.\n                           104:378 (2007).","journal-title":"Anesth. Analg."},{"key":"9571_CR76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/09680519040100030501","volume":"10","author":"K. Kaneko","year":"2004","unstructured":"K. Kaneko, R. Ueda, T. Kawata, S. Ishizaka, and T. Yoshimura. LPS binding protein does not participate in the pharmacokinetics of E5564. J. Endotoxin Res.\n                           10:185 (2004).","journal-title":"J. Endotoxin Res."},{"key":"9571_CR77","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00011-006-6057-3","volume":"55","author":"E. Czeslick","year":"2006","unstructured":"E. Czeslick, A. Struppert, A. Simm, and A. Sablotzki. E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes. Inflamm. Res.\n                           55:511 (2006).","journal-title":"Inflamm. Res."},{"key":"9571_CR78","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.2174\/138161206778743484","volume":"12","author":"K. J. Ishii","year":"2006","unstructured":"K. J. Ishii, S. Uematsu, and S. Akira. \u2018Toll\u2019 gates for future immunotherapy. Curr. Pharm. Des.\n                           12:4135\u20134142 (2006).","journal-title":"Curr. Pharm. Des."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-008-9571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-008-9571-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-008-9571-x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-008-9571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T15:52:05Z","timestamp":1630425125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-008-9571-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,21]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9571"],"URL":"https:\/\/doi.org\/10.1007\/s11095-008-9571-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,21]]},"assertion":[{"value":"18 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}